Global study finds plasma therapy isn't helping severely ill coronavirus patients
Blood samples
Does plasma therapy work for coronavirus patients? A global trial which tested blood plasma on coronavirus patients with moderate to severe illnesses claims it does very little to alleviate trouble for patients.
Owing to no change in condition, the trial has stopped the enrolment of severe coronavirus cases in need of intensive care, Reuters reported.
The REMAP-CAP is an international trial which is looking at potential treatments for the virus. As part of this trial, it had recruited 4,100 coronavirus patients spread out across 290 sites in Europe, the Americas, Africa, Asia, and Australia.
The trial showed how 900 patients who were severely ill, and in need of intensive care, did not respond well to the treatment with antibody-rich plasma taken from people who had already recovered from the virus.
The treatment did not improve outcomes among patients, painting a grim picture of a treatment which has been employed by governments across the world in a bid to limit the spread of infection, and to control the death rate.
&im=FitAndFill=(700,400))
National Handloom Day 2026: From Alia Bhatt to Samantha Ruth Prabhu; Actresses who celebrated India's textile heritage as brides
)
The Royals enter the Doctor Who universe: King Charles and Queen Camilla beam into Commonwealth Games in TARDIS
)
Unitree Robotics targets $9 billion valuation in landmark IPO backed by DeepSeek and Tencent
)
India names 27 sites in Arunachal Pradesh
)
Bharat Bhhagya Viddhaata OTT: When will Kangana Ranaut's film stream online?
&im=FitAndFill=(700,400))
How many soldiers operate one S-400 battery?
)
Shakib Al Hasan ready to return to Bangladesh—under one condition
)
‘Fake news’: MEA rejects report claiming India sought defence pact with Israel after Pakistan, Saudi Arabia, Turkey deal
)
Rockstar to unveil GTA 6 extended look ahead of November launch
)
Russia forms Ukrainian Volunteer Spetsnaz Brigade to fight Ukraine
)
Drug-resistant fungus that hides in hair and enters bloodstream reported in 23 US states
)
Technology transfer deal boosts India's defence manufacturing ambitions
)
Border row erupts in Europe after Ceuta crossings, Spain imposes border controls on Italy
)
Morale plummets on USS Abraham Lincoln: Are US sailors reaching a breaking point? | GRAVITAS
)
'Security can't be bought with Pakistan, Turkey deal': Iran tells Saudi Arabia
)
Baba Vanga's 2026 prophecy: 2 predictions 'already came true', 3 terrifying ones remain. Details inside
)
Colombia’s new president Abelardo de la Espriella vows to ‘defeat narco-terrorists’, signals hardline shift
&im=FitAndFill=(700,400))
New Friday OTT releases (August 7, 2026): Operation Safed Sagar, Vadhandhi, Main Vaapis Aaunga- 6 movies and TV shows on Netflix, Prime Video and more
)
Squadron Leader Bhawana Kanth scripts history as Indian Air Force gets its first woman ‘Top Gun’ pilot
)
RSS says Gen Z protests reflect genuine distress
)
Trump says Iranian school bombing photos could be AI-generated - 'I don’t think...'
)
IAF officer held for sharing sensitive information in 'honey trap' case, booked under Official Secrets Act
)
Stray Kids under scrutiny? Fans react to Grammy submission silence after BTS boycott
&im=FitAndFill=(700,400))
Why the Su-30MKI doesn't need external fuel tanks to fly vast distances
)
Jugal Hansraj reunites with Shekhar Kapur after 40 years for Masoom: The Next Generation
)
New speed limits, automatic challans: Big traffic change coming to Delhi-Meerut Expressway. All you need to know
)
India officially names 27 places in Arunachal to counter China's renaming claims
)
Trump calls White House ballroom ruling a 'national disgrace' as court says Congress approval needed
)
US sanctions Iran’s crypto network after Strait of Hormuz attacks, offers $15m bounty for intel on IRGC finance
&im=FitAndFill=(700,400))
Why the Su-30MKI is one of the heaviest fighters ever built
)
Uttarakhand young innovator builds India's own flying vehicle, conducts first test flight: WATCH
)
Chilling video shows students take cover as teen opens fire at Thai school
)
Reese Witherspoon's father hospitalised after poolside incident in Nashville: Report
Also read:Does plasma therapy help coronavirus patients? This study reveals shocking results
Even then, scientists did not find evidence of any harm associated with the plasma treatment, and will continue to induct patients who are hospitalised with moderate illness, they claimed in a statement.
Patients who are not producing antibodies during therapy, and those carrying a high load of the virus might be benefitting from the treatment, something the researchers intend to explore in the future course of this study.
Also read:Plasma jets may kill coronavirus in seconds: Study
The basic rationale behind convalescent plasma therapy is that antibodies from recovered patients could effectively neutralise the virus, preventing it from spreading further and damaging tissues.
The treatment has a very low probability of reducing death rates and the number of days patients need in intensive care - a meagre 2.2 per cent, the researchers found.
Earlier, findings from another REMAP-CAP trial found that arthritis drugs like Roche's Actemra and Sanofi's Kevzara were effective in preventing deaths, and reducing the time patients spend in intensive care.